Therefore, G6PD is reported to be a prognostic marker.27–29 Additionally, our recent study of MCC demonstrated that G6PD is not only a prognostic predictor, but also a useful marker for judging the potential immune activity of a tumor. This evidence concerns the gene G6PD and neoplasm.